News

We are proud to welcome our 45th client. What started as an ambition to help innovative biotech and pharmaceutical companies navigate the Swiss healthcare landscape has grown into 45 trusted client partnerships. Over the years, we have had the privilege of supporting companies across all stages of their Swiss market journey – from market entry and market access to launch readiness and commercial execution. A sincere thank you to our clients, partners and team members for bein

Switzerland is often perceived as a “small market” – which sometimes leads to one of two extremes: being deprioritised, or being overengineered from day one. Based on our experience, successful rare disease launches in Switzerland are not about size or complexity, but about making the right decisions at the right time. A smart entry to the Swiss market takes a holistic view and considers: Swissmedic regulatory requirements market access pathways and reimbursement strategy lea

The number of clients that have placed their confidence in Swizzard has grown steadily over the past five years. Today, we’re proud to have worked with 40 visionary biotech and pharma companies as they navigate the Swiss landscape. As momentum picks up and Swizzard’s client base continues to grow, our role is unchanged: we’re committed to bringing decision-ready insights, pragmatic options, strategic advice and measurable results. From market shaping and access planning to la

We’re celebrating five years of Swizzard! Swizzard was founded at the beginning of 2021 with a clear ambition: to help bring medical breakthroughs to Swiss patients. Today, we’re proud of what we’ve achieved thanks to our innovative clients and an exceptional team. Together, we’ve helped 39 biotech companies establish and grow their Swiss presence, advancing innovations across oncology, metabolism, dermatology, neurology and beyond, with a strong focus on rare diseases. Alo

Swizzard Pharma AG, a solution provider that supports biotech and pharma companies in successfully entering and thriving in the Swiss market, welcomes Philipp Heider as Medical & Market Access Associate Director. Philipp holds a Master of Science in Biotechnology from the Management Center Innsbruck and recently completed a CAS in Digital Life Sciences at Zurich University of Applied Sciences (ZHAW). His academic profile is complemented by certifications in Good Clinical Pra

As the year comes to an end, we took a moment to gather with our team and valued partners for a festive evening filled with reflection, gratitude, and shared achievements. It was a wonderful opportunity to celebrate the strong sense of collaboration that defines our work. For us, the holiday season is about more than festivities — it’s about giving back and creating meaningful connections. We’re honored to continue supporting CO-OPERAID for the fourth year in a row, helping y